An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

NCT06067984 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
73
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Click Therapeutics, Inc.

Collaborators